195 filings
Page 5 of 10
8-K
lb98 6tsj67as
27 Apr 21
Regulation FD Disclosure
5:01pm
8-K
rxeffq
8 Apr 21
Provention Bio Provides Regulatory Update on Biologics License Application for Teplizumab
4:05pm
DEFA14A
gxh d4tuimp
29 Mar 21
Additional proxy soliciting materials
4:10pm
PRE 14A
451s gj8h6h5kj5e6
19 Mar 21
Preliminary proxy
4:20pm
S-8
rn7h32f
26 Feb 21
Registration of securities for employees
5:22pm
424B5
ysqu6r7ff
26 Feb 21
Prospectus supplement for primary offering
5:19pm
8-K
murgvs v826ky5dfyfj
26 Feb 21
Other Events
5:04pm
8-K
xblq5
25 Feb 21
Provention Bio Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
7:21am
8-K
9qkb4672tym5j 7cho
15 Jan 21
Entry into a Material Definitive Agreement
4:43pm
424B5
2j9 p21rqkqlu
15 Jan 21
Prospectus supplement for primary offering
4:28pm
8-K
ri9c7t22y8ehq
12 Jan 21
Results of Operations and Financial Condition
5:25pm
424B5
r51 4qt0zlei82
12 Jan 21
Prospectus supplement for primary offering
5:16pm
S-3ASR
40xst4da0 k4
12 Jan 21
Automatic shelf registration
4:08pm
S-8
rlu 9nm7zu0yb3cf
5 Nov 20
Registration of securities for employees
4:06pm
8-K
bu029wwlsxjoj5 3a8
5 Nov 20
Provention Bio Reports Third Quarter 2020 Financial Results and Provides Business Update
7:21am
8-K
iwzvvj7kmnyekney
30 Oct 20
Departure of Directors or Certain Officers
4:15pm
UPLOAD
2kc g418ofw3
24 Aug 20
Letter from SEC
12:00am